UK industry clinical trial performance shows signs of improvement, says ABPI report
The decline in the number of industry clinical trials initiated in the UK shows welcome early signs of recovery. However, progress is not yet enough to restore the UK’s global ranking on trials.
Read the full articleYou might also wanna read
Zhaohui Su Reports Rising Protocol Complexity Across 190,000 Clinical Trials
OncoDaily·1d ago
ABPI response to Life Sciences Competitiveness Indicators
ABPI·2d ago
Unlocking NHS data to increase recruitment into clinical trials will give the UK a competitive edge, says ABPI
ABPI·4d ago
ABPI welcomes new NHS research guidance
ABPI·4d ago
ABPI response to Lord O'Shaughnessy Review
ABPI·4d ago
10-year Moderna deal underlines UK potential for global life science leadership
ABPI·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.